BACKGROUND: Rates of sexually transmitted infections (STIs) and HIV are highest in the southern United States but vary widely by sex, age, and risk behavior. Current guidelines recommend annual screening for chlamydia, gonorrhea, syphilis, and trichomoniasis in all sexually active women with HIV. METHODS: Screening rates and test positivity for chlamydia, gonorrhea, syphilis, and trichomoniasis were determined per calendar year in this retrospective cohort study of women in care at an urban HIV clinic in Birmingham, Alabama, from 2013 to 2015. Chlamydia, gonorrhea, and trichomonas infections were detected by molecular diagnostics and syphilis by serology. A combined end point for chlamydia/gonorrhea/syphilis (STI-3) was created based on similar test positivity and predictors. Predictors of STI-3 were identified using logistic regression and generalized estimating equations. RESULTS: Among 745 women with HIV, median age was 46.8 years, 78.8% were black, and 61% were sexually active. In 2015, 83.7% of women were tested for STI. Test positivity was 1.0% for chlamydia, 0.5% for gonorrhea, 1.6% for syphilis, and 13.3% for trichomoniasis. Independent predictors of STI-3 were recent chlamydia or gonorrhea (odds ratio [OR], 3.7; 95% confidence interval [CI], 1-13.4; P = 0.047), public insurance compared with private (OR, 3.5; CI, 1-11.8; P = 0.048), and sex after drugs/alcohol (OR, 3.0; CI, 1.2-8.0; P = 0.025). Women 50 years or older were less likely to have STI (OR, 0.3; CI, 0.1-1; P = 0.040). CONCLUSIONS: In a cohort of women engaged in HIV care in the southern United States, detection of chlamydia, gonorrhea, and syphilis was infrequent but trichomoniasis was common. Many women screened for STI were low risk and universal testing strategies warrant evaluation.
BACKGROUND: Rates of sexually transmitted infections (STIs) and HIV are highest in the southern United States but vary widely by sex, age, and risk behavior. Current guidelines recommend annual screening for chlamydia, gonorrhea, syphilis, and trichomoniasis in all sexually active women with HIV. METHODS: Screening rates and test positivity for chlamydia, gonorrhea, syphilis, and trichomoniasis were determined per calendar year in this retrospective cohort study of women in care at an urban HIV clinic in Birmingham, Alabama, from 2013 to 2015. Chlamydia, gonorrhea, and trichomonas infections were detected by molecular diagnostics and syphilis by serology. A combined end point for chlamydia/gonorrhea/syphilis (STI-3) was created based on similar test positivity and predictors. Predictors of STI-3 were identified using logistic regression and generalized estimating equations. RESULTS: Among 745 women with HIV, median age was 46.8 years, 78.8% were black, and 61% were sexually active. In 2015, 83.7% of women were tested for STI. Test positivity was 1.0% for chlamydia, 0.5% for gonorrhea, 1.6% for syphilis, and 13.3% for trichomoniasis. Independent predictors of STI-3 were recent chlamydia or gonorrhea (odds ratio [OR], 3.7; 95% confidence interval [CI], 1-13.4; P = 0.047), public insurance compared with private (OR, 3.5; CI, 1-11.8; P = 0.048), and sex after drugs/alcohol (OR, 3.0; CI, 1.2-8.0; P = 0.025). Women 50 years or older were less likely to have STI (OR, 0.3; CI, 0.1-1; P = 0.040). CONCLUSIONS: In a cohort of women engaged in HIV care in the southern United States, detection of chlamydia, gonorrhea, and syphilis was infrequent but trichomoniasis was common. Many women screened for STI were low risk and universal testing strategies warrant evaluation.
Authors: Julia R Raifman; Kelly A Gebo; William Christopher Mathews; Philip Todd Korthuis; Khalil G Ghanem; Judith A Aberg; Richard D Moore; Ank E Nijhawan; Anne K Monroe; Stephen A Berry Journal: J Acquir Immune Defic Syndr Date: 2017-12-01 Impact factor: 3.731
Authors: Lisa E Manhart; Jeanne M Marrazzo; David N Fine; Roxanne P Kerani; Matthew R Golden Journal: J Infect Dis Date: 2007-07-17 Impact factor: 5.226
Authors: Bonnie B Dean; Mia Scott; Rachel Hart; Linda Battalora; Richard M Novak; Marcus D Durham; John T Brooks; Kate Buchacz Journal: Sex Transm Dis Date: 2017-11 Impact factor: 2.830
Authors: Alex de Voux; Sarah Kidd; Jeremy A Grey; Eli S Rosenberg; Thomas L Gift; Hillard Weinstock; Kyle T Bernstein Journal: MMWR Morb Mortal Wkly Rep Date: 2017-04-07 Impact factor: 17.586
Authors: J Carlo Hojilla; Varada Sarovar; Jennifer O Lam; Ina U Park; Wilson Vincent; C Bradley Hare; Michael J Silverberg; Derek D Satre Journal: AIDS Behav Date: 2022-08-02
Authors: Jodie Dionne-Odom; Andrew O Westfall; Julia C Dombrowski; Mari M Kitahata; Heidi M Crane; Michael J Mugavero; Richard D Moore; Maile Karris; Katerina Christopoulos; Elvin Geng; Kenneth H Mayer; Jeanne Marrazzo Journal: Clin Infect Dis Date: 2020-12-03 Impact factor: 9.079
Authors: Jodie Dionne-Odom; Kimberly Workowski; Charlotte Perlowski; Stephanie N Taylor; Kenneth H Mayer; Candice J McNeil; Matthew M Hamill; Julia C Dombrowski; Teresa A Batteiger; Arlene C Sena; Harold C Wiesenfeld; Lori Newman; Edward W Hook Journal: Sex Transm Dis Date: 2022-01-24 Impact factor: 3.868
Authors: Maria C Geba; Samuel Powers; Brooke Williams; Kathryn R Dort; Elizabeth T Rogawski McQuade; Kathleen A McManus Journal: Open Forum Infect Dis Date: 2022-07-01 Impact factor: 4.423
Authors: Ruth J Geller; Michele R Decker; Adebola A Adedimeji; Kathleen M Weber; Seble Kassaye; Tonya N Taylor; Jennifer Cohen; Adaora A Adimora; Lisa B Haddad; Margaret Fischl; Sarah Cunningham; Elizabeth T Golub Journal: J Womens Health (Larchmt) Date: 2020-09-30 Impact factor: 2.681